Breast cancer size in postmenopausal women is correlated with body mass index and androgen serum levels

Gynecological Endocrinology

Volumn 18, Issue 1, 2004, Pages 29-36

  Asseryanis, E ^a   Ruecklinger, E ^b   Hellan, M ^a   Kubista, E ^a   Singer, C F ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Ruecklinger KEG   (Austria)

Author keywords

Androstenedione; BMI; Breast Cancer; DHEAS; Tumor Size

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTENEDIONE; ESTRADIOL; ESTROGEN RECEPTOR; HORMONE RECEPTOR; LEPTIN; PRASTERONE SULFATE; PROGESTERONE RECEPTOR; SEX HORMONE; TESTOSTERONE;

ADULT; AGE; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BLOOD LEVEL; BODY MASS; BODY WEIGHT; BREAST CANCER; CANCER GROWTH; CANCER SIZE; CANCER SURGERY; CAUCASIAN; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

ADULT; ANDROSTENEDIONE; BODY MASS INDEX; BREAST NEOPLASMS; DEHYDROEPIANDROSTERONE SULFATE; ESTRADIOL; FEMALE; HUMANS; LEPTIN; MENOPAUSE; MIDDLE AGED; TESTOSTERONE;

EID: 1642578256     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/09513590310001651759     Document Type: Article

References (34)

1. Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 2001;10:15-32
2. McTiernan A. Review of anthropometric factors and breast cancer risk. Cancer 2000;88(Suppl 5):1248-55
3. Suga K, Imai K, Eguchi H, et al. Molecular significance of excess body weight in postmenopausal breast cancer patients, in relation to expression of insulin-like growth factor I receptor and insulin-like growth factor II genes. Jpn J Cancer Res 2001;92: 127-34
4. Wynder EL, Cohen LA, Winters BL. The challenges of assessing fat intake in cancer research investigations. J Am Diet Assoc 1997;97(Suppl 7):S5-8
5. Chang S, Alderfer JR, Asmar L, et al. Inflammatory breast cancer survival: the role of obesity and menopausal status at diagnosis. Breast Cancer Res Treat 2001; 64:157-63
6. Jain M, Miller AB. Tumor characteristics and survival of breast cancer patients in relation to premorbid diet and body size. Breast Cancer Res Treat 1997;42:43-55
7. Honda H, Ohi Y, Umekita Y, et al. Obesity affects expression of progesterone receptors and node metastasis of mammary carcinomas in postmenopausal women without a family history. Pathol Int 1999; 49:198-202
8. Willett WC. Diet and breast cancer. J Intern Med 2001;249:395-411
9. Tagliaferri M, Cohen I, Tripathy D. Complementary and alternative medicine in early-stage breast cancer. Semin Oncol 2001;28:121-34
10. Zamboni M, Armellini F, Harris T, et al. Effects of age on body fat distribution and cardiovascular risk factors in women. Am J Clin Nutr 1997;66:111-15
11. Rochefort H. Estrogen-induced genes in breast cancer, and their medical importance. Bull Acad Natl Med 1999;183:955-68
12. Moudgil VK, Dinda S, Khattree N, et al. Hormonal regulation of tumor suppressor proteins in breast cancer cells. J Steroid Biochem Mol Biol 2001;76:105-17
13. Azziz R. Reproductive endocrinologic alterations in female asymptomatic obesity. Fertil Steril 1989;52: 703-25
14. Adams JB. Adrenal androgens and human breast cancer: a new appraisal. Breast Cancer Res Treat 1998;51:183-8
15. Cleary MP, Maihle NJ. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med 1997;216:28-43
16. Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serum sex hormones and breast cancer risk in postmenopausal women. J Natl Cancer Instit 2003;95: 1218-26
17. Rock CL, Flatt SW, Newman V, et al. Factors associated with weight gain in women after diagnosis of breast cancer. Women's Healthy Eating and Living Study Group. J Am Diet Assoc 1999;99:1212-21
18. Colombel A, Charbonnel B. Weight gain and cardiovascular risk factors in the postmenopausal women. Hum Reprod 1997;12(Suppl 1):134-45
19. Overlie I, Moen MH, Morkrid L, et al. The enodcrine transition around menopause - a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women. Acta Obstet Gynecol Scand 1999;78:642-7
20. Casson PR, Carson SA. Androgen replacement therapy in women: myths and realities. Int J Fertil Menopausal Stud 1996;41:412-22
21. Hunt KA, Sickles EA. Effect of obesity on screening mammography: outcomes analysis of 88,346 consecutive examinations. Am J Roentgenol 2000; 174:1251-5
22. Newman SC, Lees AW, Jenkins HJ. The effect of body mass index and oestrogen receptor level on survival of breast cancer patients. Int J Epidemiol 1997;26:484-90
23. Katoh A, Watzlaf VJ, D'Amico F. An examination of obesity and breast cancer survival in post-menopausal women. Br J Cancer 1994;70:928-33
24. Hebert JR, Augustine A, Barone J, et al. Weight, height and body mass index in the prognosis of breast cancer: early results of a prospective study. Int J Cancer 1988;42:315-18
25. Fontaine KR, Heo M, Allison DB. Body weight and cancer screening among women. J Wom Health Gend Based Med 2001;10:463-70
26. Guest AR, Helvie MA, Chan HP, et al. Adverse effects of increased body weight on quantitative measures of mammographic image quality. Am J Roentgenol 2000;175:805-10
27. Billich A, Nussbaumer P, Lehr P. Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors. J Steroid Biochem Mol Biol 2000;73:225-35
28. Le Bail JC, Allen K, Nicolas JC, et al. Dehydroepiandrosterone sulfate estrogenic action at its physiological plasma concentration in human breast cancer cell lines. Anticancer Res 1998;18:1683-8
29. Begin D, Luthy IA, Labrie F. Adrenal precursor C19 steroids are potent stimulators of growth of androgen-sensitive mouse mammary carcinoma Shionogi cells in vitro. Mol Cell Endocrinol 1988;58:213-19
30. Poortman J, Prenen JA, Schwarz F, et al. Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue. J Clin Endocrinol Metab 1975;40:373-9
31. De Pergola G, Zamboni M, Sciaraffia M, et al. Body fat accumulation is possibly responsible for lower dehydroepiandrosterone circulating levels in premenopausal obese women. Int J Obes Relat Metab Disord 1996;20:1105-10
32. Maccario M, Mazza E, Ramunni J, et al. Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women. Clin Endocrinol (Oxf) 1999;50:595-600
33. Gunasegaram R, Peh KL, Loganath A, et al. Expression of 3beta-hydroxysteroid dehydrogenase-5,4-en isomerase activity by infiltrating ductal human breast carcinoma in vitro. Breast Cancer Res Treat 1998;50: 117-23
34. Gingras S, Cote S, Simard J. Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells. Mol Endocrinol 2000;14:229-40